Absolutely nothing that I'm aware of. It just happens to be one of the hardest hit during the IBB meltdown in April. All the bios are coming back it appears and ISIS, because it does have an extensive pipeline, could really pop on the IBB reversal in the next few weeks/months imo. Cramer did a stint about the IBB chart reversal last night and he liked Celgene, Regeneron, and ISIS. But no, there is no catalyst or forward looking event that I'm following with this one, just a gut feeling- hoping for a pop back to the $40-50 range.
News 
Market Data 
Discover 
